<code id='7EF719B2B6'></code><style id='7EF719B2B6'></style>
    • <acronym id='7EF719B2B6'></acronym>
      <center id='7EF719B2B6'><center id='7EF719B2B6'><tfoot id='7EF719B2B6'></tfoot></center><abbr id='7EF719B2B6'><dir id='7EF719B2B6'><tfoot id='7EF719B2B6'></tfoot><noframes id='7EF719B2B6'>

    • <optgroup id='7EF719B2B6'><strike id='7EF719B2B6'><sup id='7EF719B2B6'></sup></strike><code id='7EF719B2B6'></code></optgroup>
        1. <b id='7EF719B2B6'><label id='7EF719B2B6'><select id='7EF719B2B6'><dt id='7EF719B2B6'><span id='7EF719B2B6'></span></dt></select></label></b><u id='7EF719B2B6'></u>
          <i id='7EF719B2B6'><strike id='7EF719B2B6'><tt id='7EF719B2B6'><pre id='7EF719B2B6'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:63
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Twill hunts for pharma partner to market its depression app
          Twill hunts for pharma partner to market its depression app

          AlexHogan/STATInanothersignofthebusinessheadwindsfacingprescriptionmentalhealthapps,developerTwillwi

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Doctors in states that ban abortion can still help patients

          ANGELAWEISS/AFPviaGettyImagesFornow,abortionremainsaccessibleeveninstateswhereit’sbanned—atleastfort